These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9780247

  • 21. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M, Pozniak A, McManus TJ, Vergani D, Peakman M.
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [Abstract] [Full Text] [Related]

  • 22. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R, Bratt G, Holmberg V, Muirhead K, Sandström E.
    Cytometry; 1998 Oct 01; 33(2):115-22. PubMed ID: 9773871
    [Abstract] [Full Text] [Related]

  • 23. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.
    J Med Virol; 2016 Aug 01; 88(8):1347-56. PubMed ID: 26765625
    [Abstract] [Full Text] [Related]

  • 24. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
    Hultin LE, Matud JL, Giorgi JV.
    Cytometry; 1998 Oct 01; 33(2):123-32. PubMed ID: 9773872
    [Abstract] [Full Text] [Related]

  • 25. Major expansions of select CD8+ subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease.
    Lynne JE, Schmid I, Matud JL, Hirji K, Buessow S, Shlian DM, Giorgi JV.
    J Infect Dis; 1998 Apr 01; 177(4):1083-7. PubMed ID: 9534988
    [Abstract] [Full Text] [Related]

  • 26. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.
    J Acquir Immune Defic Syndr; 2005 Apr 01; 38(4):373-81. PubMed ID: 15764953
    [Abstract] [Full Text] [Related]

  • 27. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy.
    Viganó A, Saresella M, Rusconi S, Ferrante P, Clerici M.
    Lancet; 1998 Dec 12; 352(9144):1905-6. PubMed ID: 9863793
    [No Abstract] [Full Text] [Related]

  • 28. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J, Phair JP.
    J Infect Dis; 1994 Oct 12; 170(4):775-81. PubMed ID: 7930717
    [Abstract] [Full Text] [Related]

  • 29. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F, Levacher-Clergeot M, Dazza MC, Strauss KW, Girard PM, Ruggeri C, Sinet M.
    AIDS Res Hum Retroviruses; 1996 Jan 01; 12(1):17-24. PubMed ID: 8825614
    [Abstract] [Full Text] [Related]

  • 30. CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
    Benito JM, López M, Lozano S, Martinez P, González-Lahoz J, Soriano V.
    AIDS Res Hum Retroviruses; 2004 Feb 01; 20(2):227-33. PubMed ID: 15018711
    [Abstract] [Full Text] [Related]

  • 31. Maintenance of naive and Th1 CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens.
    Meroni L, Manganaro D, Varchetta S, Gatti N, Riva A, Monforte AD, Galli M.
    J Acquir Immune Defic Syndr; 2001 Dec 01; 28(4):401-3. PubMed ID: 11707681
    [No Abstract] [Full Text] [Related]

  • 32. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G.
    AIDS; 1996 Jul 01; 10(8):827-34. PubMed ID: 8828739
    [Abstract] [Full Text] [Related]

  • 33. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
    Kelleher AD, Carr A, Zaunders J, Cooper DA.
    J Infect Dis; 1996 Feb 01; 173(2):321-9. PubMed ID: 8568292
    [Abstract] [Full Text] [Related]

  • 34. Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules.
    Horikoshi H, Kinomoto M, Sasao F, Mukai T, Luftig RB, Ikuta K.
    Virus Res; 2001 Jan 01; 73(1):1-16. PubMed ID: 11163640
    [Abstract] [Full Text] [Related]

  • 35. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.
    Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, Shih R, Lewis J, Wiley DJ, Phair JP, Wolinsky SM, Detels R.
    J Infect Dis; 1999 Apr 01; 179(4):859-70. PubMed ID: 10068581
    [Abstract] [Full Text] [Related]

  • 36. Subcutaneous interleukin-2 in combination with anti-retroviral therapy for treatment of HIV-1-infected subjects.
    Larsen CS, Ostergård L, Møller BK, Buhl MR.
    Scand J Infect Dis; 2000 Apr 01; 32(2):153-60. PubMed ID: 10826900
    [Abstract] [Full Text] [Related]

  • 37. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection.
    Doisne JM, Urrutia A, Lacabaratz-Porret C, Goujard C, Meyer L, Chaix ML, Sinet M, Venet A.
    J Immunol; 2004 Aug 15; 173(4):2410-8. PubMed ID: 15294954
    [Abstract] [Full Text] [Related]

  • 38. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
    Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D.
    Blood; 2000 Jan 01; 95(1):249-55. PubMed ID: 10607709
    [Abstract] [Full Text] [Related]

  • 39. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomão R, Kallas EG.
    Clin Exp Immunol; 2002 Apr 01; 128(1):149-54. PubMed ID: 11982602
    [Abstract] [Full Text] [Related]

  • 40. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME, Shearer WT, Kozinetz CA, Lewis DE.
    J Allergy Clin Immunol; 2001 Aug 01; 108(2):258-64. PubMed ID: 11496243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.